Chargement en cours...
SMYD3 overexpression indicates poor prognosis and promotes cell proliferation, migration and invasion in non-small cell lung cancer
SET and MYND domain-containing protein 3 (SMYD3) is a lysine methyltransferase, and its aberrant expression has been implicated in several malignancies. However, its clinical and biological roles in non-small cell lung cancer (NSCLC) remain unclear. In the present study, it was revealed that SMYD3 w...
Enregistré dans:
| Publié dans: | Int J Oncol |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
D.A. Spandidos
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7384847/ https://ncbi.nlm.nih.gov/pubmed/32705243 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2020.5095 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|